Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Barnes

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
BMJ (Clinical Research Ed.)|March 1, 2012
Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trialMike J Crawford, Helen Killaspy, Thomas R E Barnes, et al.
Therapeutic Advances in Psychopharmacology|May 5, 2022
The clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): a randomised placebo-controlled trialMike J Crawford, Verity C Leeson, Rachel Evans, et al.
Trials|June 9, 2019
Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2)Belinda Lennox, Ksenija Yeeles, Peter B Jones, et al.
Molecular Psychiatry|March 4, 2009
Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal functionP R Maycox, F Kelly, A Taylor, et al.
Brain, Behavior, and Immunity|July 9, 2023
Inflammatory subgroups of schizophrenia and their association with brain structure: A semi-supervised machine learning examination of heterogeneityParis Alexandros Lalousis, Lianne Schmaal, Stephen J Wood, et al.
Journal of Neuroscience Research|May 4, 2011
Transcription and pathway analysis of the superior temporal cortex and anterior prefrontal cortex in schizophreniaMichael R Barnes, Julie Huxley-Jones, Peter R Maycox, et al.
Translational Psychiatry|September 18, 2023
Network analysis of inflammation and symptoms in recent onset schizophrenia and the influence of minocycline during a clinical trialSarah E Herniman, Stephen J Wood, Golam Khandaker, et al.
Schizophrenia Research|August 14, 2024
Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and meta-analysis of individual patient dataMarc W H Lochmann van Bennekom, Joanna IntHout, Harm J Gijsman, et al.
The Lancet. Psychiatry|October 17, 2018
The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trialBill Deakin, John Suckling, Thomas R E Barnes, et al.
Trials|October 6, 2023
Antidepressants for the prevention of depression following first-episode psychosis (ADEPP): study protocol for a multi-centre, double-blind, randomised controlled trialEdward R Palmer, Siân Lowri Griffiths, Ben Watkins, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
BMJ (Clinical Research Ed.)|March 1, 2012
Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trialMike J Crawford, Helen Killaspy, Thomas R E Barnes, et al.
Therapeutic Advances in Psychopharmacology|May 5, 2022
The clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): a randomised placebo-controlled trialMike J Crawford, Verity C Leeson, Rachel Evans, et al.
Trials|June 9, 2019
Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2)Belinda Lennox, Ksenija Yeeles, Peter B Jones, et al.
Molecular Psychiatry|March 4, 2009
Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal functionP R Maycox, F Kelly, A Taylor, et al.
Brain, Behavior, and Immunity|July 9, 2023
Inflammatory subgroups of schizophrenia and their association with brain structure: A semi-supervised machine learning examination of heterogeneityParis Alexandros Lalousis, Lianne Schmaal, Stephen J Wood, et al.
Journal of Neuroscience Research|May 4, 2011
Transcription and pathway analysis of the superior temporal cortex and anterior prefrontal cortex in schizophreniaMichael R Barnes, Julie Huxley-Jones, Peter R Maycox, et al.
Translational Psychiatry|September 18, 2023
Network analysis of inflammation and symptoms in recent onset schizophrenia and the influence of minocycline during a clinical trialSarah E Herniman, Stephen J Wood, Golam Khandaker, et al.
Schizophrenia Research|August 14, 2024
Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and meta-analysis of individual patient dataMarc W H Lochmann van Bennekom, Joanna IntHout, Harm J Gijsman, et al.
The Lancet. Psychiatry|October 17, 2018
The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trialBill Deakin, John Suckling, Thomas R E Barnes, et al.
Trials|October 6, 2023
Antidepressants for the prevention of depression following first-episode psychosis (ADEPP): study protocol for a multi-centre, double-blind, randomised controlled trialEdward R Palmer, Siân Lowri Griffiths, Ben Watkins, et al.
Pageof 14